Adani Power Surpasses Infosys in Market Cap Amid Energy Demand Shift Reddit Shares Decline Following Metas Launch of Forum App for Facebook Groups CBS and Paramount Withdraw Copyright Challenges Following Stephen Colbert Parody Incident Workday Jumps 5 After Raising Margin Forecast on AIDriven Gains Standard Chartered CEO Apologizes for LowerValue Human Capital Remark Amid AIDriven Job Cuts Steel Stocks Rally as Government Extends Minimum Import Price on 66 Steel Products Lineage Cell Therapeutics Inc LCTX Q1 2026 Earnings Miss on EPS as ClinicalStage Biotech Continues Development Nuburu Q3 2023 Earnings Narrowing Losses Amid Operational Progress OnKure Therapeutics OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline CGNT Q1 2026 Earnings EPS Surges Past Estimates with 126 Surprise PM Q1 2026 Earnings EPS Surpasses Estimates by 414 TKC Q4 2025 Earnings Mixed Performance Amidst Currency Headwinds and Margin Pressures BioLife Solutions BLFS Faces Headwinds Shares Decline 319 to 2395 Rezolve AI RZLV Declines 209 Approaching Critical Support at 245 Fortune Brands Innovations FBIN Rallies 273 as Home Improvement Sentiment Improves TechnipFMC FTI Consolidates Near 7141 Holding Support Above Key Level Onconetix Inc ONCO Edges Higher Amid Consolidation Near Key Resistance Geosphere Capitals Arvind Sanger Cautiously Optimistic on India Amid Global Liquidity Outlook ABR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Real Estate Market GJR Synthetic FixedIncome Securities Inc STRATS Trust Holds Steady at 2475 Minimal Movement Reflects BondLike Profile VRTX Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick NSP Q1 2026 Earnings EPS Surpasses Estimates as Stock Rises Nuwellis Q1 2026 Earnings Significant EPS Miss Despite Stock Gain BGSI Q1 2026 Earnings Earnings Slightly Miss Estimates as Stock Edges Lower AMP Q1 2026 Earnings EPS Beats Estimates by 923 as Wealth Management Segment Drives Results TSQ Q1 2026 Earnings EPS Misses Estimates Amid Challenging Ad Environment Ocugen Inc OCGN Q1 2026 Earnings Wider Loss Misses Estimate as PreRevenue Biotech Focuses on Pipeline